Complement Factor H Activity Assay

Creative Biolabs offers comprehensive complement factor H (CFH) activity assay services to support academic, translational, and biopharmaceutical research programs focused on complement biology and complement-targeted therapeutic development. We provide flexible and mechanism-resolved assay solutions that can be configured to measure multiple dimensions of CFH function.

Submit Your Request Now

Download our service brochure

Inquiry

Why CFH Activity Assay Matters

The alternative complement pathway is continuously primed for activation through spontaneous C3 hydrolysis and amplification of C3b deposition. This feature allows the complement system to respond rapidly to microbial surfaces, immune complexes, damaged cells, and other danger-associated structures. However, the same amplification loop must be tightly controlled to avoid uncontrolled complement activation on host tissues. CFH provides this control by recognizing C3b and host-associated surface markers, thereby directing regulatory activity to appropriate sites.

CFH activity is not a single biochemical event. It involves several coordinated functional properties:

CFH binds C3b and related C3 fragments.
CFH competes with Factor B for C3b binding and limits formation of the alternative pathway C3 convertase.
CFH accelerates the decay of C3bBb by promoting dissociation of Bb from the convertase complex.
CFH acts as a cofactor for Factor I-mediated cleavage of C3b to inactive fragments such as iC3b.
CFH recognizes host-like polyanionic surfaces and helps distinguish self from non-self.
CFH can modulate complement activation on cell membranes, extracellular matrix, biomaterials, immune complexes, and disease-associated surfaces.

Because CFH function depends on both molecular interaction and biological context, different assay designs may answer different questions. Creative Biolabs designs CFH activity assays to match the scientific question behind each project. Whether the goal is to evaluate a disease-associated CFH mutation, compare recombinant CFH lots, characterize engineered CFH fragments, screen CFH-enhancing compounds, assess anti-CFH autoantibody interference, or benchmark complement inhibitors, our team can help select a suitable assay strategy and establish a robust testing workflow.

Great Minds Choose Creative Biolabs

Partner with Us

Creative Biolabs' CFH Activity Assay Platform

Creative Biolabs provides integrated CFH activity assay services that cover experimental design, reagent selection, assay optimization, sample testing, data analysis, and customized reporting. Our platform is suitable for early discovery, mechanism-of-action studies, lead optimization, biomarker exploration, comparability studies, and preclinical functional evaluation.

C3b Binding Activity Assay

We evaluate the interaction between CFH and C3b or C3b-derived ligands using plate-based, bead-based, surface-based, or other customized formats. This assay is suitable for determining whether CFH variants, engineered constructs, antibodies, or other molecules preserve, enhance, or inhibit C3b recognition.

Factor I Cofactor Activity Assay

We assess the ability of CFH to serve as a cofactor for Factor I-mediated cleavage of C3b. Readouts can include detection of C3b degradation fragments, iC3b generation, band pattern analysis, immunodetection, or quantitative signal-based measurements depending on project requirements.

Decay-Accelerating Activity Assay

We measure the ability of CFH to accelerate the dissociation of Bb from the alternative pathway C3 convertase C3bBb. This assay helps determine whether a sample can destabilize preformed convertase complexes and reduce alternative pathway amplification.

Alternative Pathway Inhibition Assay

We evaluate the inhibitory effect of CFH or CFH-modulating agents on alternative pathway activation in serum, plasma, purified component systems, or reconstituted assay formats. Readouts may include C3 fragment deposition, Ba generation, C5b-9 formation, or pathway-specific endpoint signals.

Surface Protection Assay

We assess whether CFH protects host-like surfaces, biomaterial surfaces, erythrocytes, endothelial-like cells, epithelial cells, or other relevant models from complement amplification and downstream injury. This assay is particularly useful for studying surface recognition and physiologically relevant complement regulation.

Hemolysis Inhibition Assay

We evaluate the capacity of CFH to prevent complement-mediated erythrocyte lysis under alternative pathway-supporting conditions. Hemolysis-based readouts provide an integrated functional endpoint for CFH-mediated protection.

Anti-CFH Antibody Interference Assay

We support studies investigating whether anti-CFH antibodies, autoantibodies, or therapeutic antibodies alter CFH activity, block C3b binding, interfere with cofactor activity, or reduce surface protection.

CFH Variant Functional Characterization

We design customized assay panels for disease-associated CFH variants, recombinant CFH mutants, domain-deletion constructs, fusion proteins, or engineered complement regulators. Multiple readouts can be combined to define how structural changes influence functional activity.

Therapeutic Candidate Screening

We support screening and ranking of complement-targeted candidates that enhance, mimic, inhibit, restore, or otherwise modulate CFH activity. These candidates may include antibodies, peptides, aptamers, small molecules, recombinant proteins, fusion proteins, nanoparticles, or gene therapy-derived products.

Discuss Your Needs

What We Test

Creative Biolabs' CFH activity assay service can be adapted to a wide range of research materials and development needs.

Recombinant and Native CFH, CFH Variants and Mutants

Assay panels can be tailored to characterize individual variants.

CFH-Related Proteins and Engineered Regulators

Evaluate CFH-related molecules, engineered regulators, fusion proteins, and domain-swapped constructs.

Therapeutic Antibodies and Biologics

Assess whether they alter CFH binding or regulatory activity.

Small Molecules, Peptides, and Aptamers

Support hit identification, lead ranking, concentration-response analysis, and mechanism-of-action studies.

Workflow of CFH Activity Assay

Creative Biolabs follows a structured workflow to ensure that each CFH activity assay is aligned with the client's scientific goals and sample requirements.

CFH assay. (Creative Biolabs Original) Fig. 1 CFH ELISA workflow (left) and CFH-mediated hemolysis inhibition assay (right).

Design Your Workflow

Readouts and Endpoints

Creative Biolabs provides flexible readout selection to support both exploratory and quantitative studies.

Binding Readouts

CFH-C3b binding signal
CFH-C3d or ligand-binding profile
Competition binding curves
Apparent binding strength under defined assay conditions

Complement Activation Readouts

C3b deposition
iC3b deposition
C3a generation
Ba generation
C5a generation
C5b-9 or terminal complement complex formation

Cell-Based Readouts

Surface C3 fragment deposition
Surface C5b-9 deposition
Cell lysis
Cell viability
Opsonization profile
Complement-mediated cytotoxicity

Hemolysis Readouts

Percent hemolysis
Hemolysis inhibition curve
Protective activity comparison
EC50 or IC50 estimation, when suitable
Endpoint or kinetic hemolysis measurement

Featured Service Packages

Service Packages	Description	Typical deliverables
CFH Basic Binding Package	This package is designed for projects that need to evaluate the interaction between CFH and C3b or other ligands. Recommended for: Recombinant CFH quality assessment CFH variant screening Antibody competition studies Ligand recognition studies	Binding signal comparison Concentration-response profile Relative binding activity Summary of binding performance
CFH Cofactor Activity Package	This package evaluates the ability of CFH to support Factor I-mediated C3b cleavage. Recommended for: CFH variant functional analysis Engineered CFH characterization Anti-CFH antibody interference studies Mechanism-of-action research	C3b cleavage profile iC3b or fragment generation analysis Relative cofactor activity Control-normalized activity comparison
CFH Decay-Acceleration Package	This package measures the ability of CFH to destabilize the alternative pathway C3 convertase. Recommended for: Alternative pathway regulatory studies Convertase-targeted therapeutic development CFH structure-function analysis Functional comparison of CFH constructs	Convertase decay profile Bb dissociation or activity loss readout Relative decay-accelerating activity Dose-response analysis when applicable
CFH Surface Protection Package	This package assesses CFH activity on host-like or disease-relevant surfaces. Recommended for: Surface recognition studies Cell-based complement regulation Disease-associated variant evaluation Therapeutic candidate assessment	Surface C3 deposition Terminal complement complex deposition Cell lysis or viability readout Protection index or relative activity score
CFH Comprehensive Functional Panel	This package integrates multiple assay formats to build a complete functional profile. Recommended for: Lead candidate selection CFH variant deep characterization Translational research studies Preclinical complement therapeutic programs	Binding activity Cofactor activity Decay-accelerating activity Alternative pathway regulation Surface protection Integrated functional interpretation

Design Your Customization

Case Studies

Case 1

Measurement of the Kd of C3b for Different Factor H Sites

Ten different recombinant Factor H protein fragments were analyzed by SPR for their affinity for C3b. The method used to measure these interactions relied on the attachment of the recombinant Factor H fragments to the Ni-NTA-coated surface of sensor chips. A similar experimental approach was used to measure the affinity of the C3b binding site at the C-terminal of Factor H.

Recombinant Factor H protein fragments were analyzed by SPR for their affinity for C3b. (OA Literature) Fig. 2 SPR analysis of the binding of recombinant Factor H to C3b.^1,2

References

Haque, Aftabul, et al. "Characterization of binding properties of individual functional sites of human complement factor H." Frontiers in immunology 11 (2020): 1728. https://doi.org/10.3389/fimmu.2020.01728
Distributed under Open Access license CC BY 4.0, without modification.

What Our Clients Say

"Creative Biolabs helped us move beyond sequence-level interpretation and generate functional evidence for several CFH variants. The team designed a clear assay panel that included C3b binding, Factor I cofactor activity, and alternative pathway regulation. The results helped us distinguish variants with reduced binding from those with more specific regulatory defects."

— Principal Investigator, Academic Complement Biology Laboratory

"Our program required a functional assay strategy that could evaluate how our candidate influenced Factor H-mediated regulation of the alternative pathway. Creative Biolabs provided thoughtful assay design, appropriate controls, and well-organized data interpretation. Their work helped us better understand whether our molecule was acting at the level of C3b interaction, convertase regulation, or downstream complement activation."

— Senior Scientist, Complement Therapeutics Company

"We needed to compare several recombinant CFH preparations generated under different expression and purification conditions. Creative Biolabs established a fit-for-purpose activity assay that allowed us to evaluate lot-to-lot functional consistency rather than relying only on purity and concentration. The final report was detailed and easy to incorporate into our internal development review."

— Director of Protein Sciences, Biologics Development Team

"Creative Biolabs was able to adapt the Factor H assay workflow to our sample type and research question. The team was responsive during assay planning and provided useful recommendations regarding serum source, controls, sample dilution, and readout selection. The customized approach saved us significant assay development time."

— Project Leader, Biotechnology R&D Department

Frequently Asked Questions

What is the difference between a Factor H binding assay and a Factor H activity assay?

A Factor H binding assay usually measures whether Factor H interacts with a ligand such as C3b, C3d, heparin-like molecules, host-like surface components, or other relevant binding partners. This type of assay is useful for studying recognition and competition. A Factor H activity assay, however, evaluates whether Factor H performs a functional regulatory role, such as acting as a Factor I cofactor, accelerating C3 convertase decay, suppressing alternative pathway amplification, or protecting cells from complement deposition. In many projects, binding and activity assays are complementary because normal binding does not always guarantee normal regulatory function.

Can the assay determine whether a Factor H variant has lost function?

Yes. Creative Biolabs can design a functional assay panel to evaluate whether a Factor H variant shows reduced, retained, enhanced, or context-dependent activity. Depending on the suspected mechanism, the panel may include C3b binding, Factor I cofactor activity, decay-accelerating activity, serum-based alternative pathway inhibition, and surface protection assays. This multi-readout strategy helps distinguish different types of functional defects.

Can Creative Biolabs test recombinant Factor H produced in different expression systems?

Yes. We can compare recombinant Factor H proteins produced in different expression systems, purification workflows, formulations, or storage conditions. Functional testing can be used to assess whether differences in production or handling affect binding, cofactor activity, convertase regulation, or pathway inhibition. This is especially useful for protein engineering, process development, lot comparison, formulation optimization, and stability studies. In addition to activity readouts, assays can be designed with appropriate reference standards and controls to support relative activity comparison across multiple recombinant Factor H preparations.

What readouts can be included in a Factor H activity assay?

Available readouts may include C3b binding, C3d binding, Factor I-mediated C3b cleavage, iC3b generation, Bb dissociation, reduction of alternative pathway C3 convertase activity, C3 fragment deposition, Ba generation, C3a release, C5a release, C5b-9 formation, hemolysis inhibition, cell viability, and surface protection. Readout selection depends on the assay format and scientific goal.

What controls are commonly used in Factor H activity assays?

Common controls may include blank controls, no-Factor H controls, wild-type Factor H controls, heat-inactivated serum controls, complement-depleted serum controls, Factor I controls, C3b-only controls, known complement inhibitors, isotype controls, vehicle controls, positive activation controls, negative surface controls, and matrix-matched controls. For antibody interference studies, additional controls may include non-specific antibodies, blocking controls, or competition conditions. Creative Biolabs selects controls based on assay type, sample matrix, complement source, and project objective.